Cambridge Capital Group has over 80 members from a variety of backgrounds ranging from finance, technology and corporate to life sciences, agriculture and engineering. Members have invested in more than 50 live portfolio companies across Europe’s leading technology cluster since 2001. During 2016 members enjoyed four successful exits: Swiftkey, Cambridge CMOS, Oval Medical and Expedeon.

We are a syndicate member of the UK Business Angels Association (UKBAA) and our membership includes two UKBAA Investors of the Year.

We focus on businesses from Seed to Series A stage raising between £150k to £2m. We invest in B2B technology companies based on defensible intellectual property - companies meeting these requirements are invited to submit their summary using the link below.

As we continue to expand our network we invite new member applications from sophisticated investors, family offices and venture capital funds.

News

News
October 2017

Cambridge Capital Group Members Celebrate their 100th Deal

We congratulate Cambridge Capital Group Members who have now made their 100th Investment.

The group has invested more than £25m into 100+ start-ups, mainly in the Cambridge cluster, still Europe’s most important B2B centre. Some companies have received £10k from a single member, others have received £1m-2m from a group syndicate. While some of our portfolio companies have failed due to the high risk nature of investing in start-ups, twelve of our portfolio companies have “exited” profitably over the years, via AIM listings or trade sales, with returns ranging from 2-15X - including four in 2016. The most notable was the $250m sale of the Swiftkey business to Microsoft.
Members of Cambridge Capital Group are private investors and family investment funds drawn from the Cambridge region, London and the Thames Valley as well as international territories such as the Channel Islands and Singapore. They boast a diverse range of sector backgrounds enabling collaboration between group members who co-invest in opportunities that interest them individually.

We therefore salute our brave 80+ members who boldly go where no angel group has gone before, supporting the next generation of hi-technology entrepreneurs in the so called Golden Triangle of Cambridge/London/Oxford - to create sustainable wealth and employment for Great Britain.


News
December 2016

Fourth Portfolio Exit in 2016.

CCG members are currently celebrating following the fourth announcement of a successful Portfolio Exit in 2016. Members invested in Oval Medical Technologies in 2010 after their first ever pitch to a group of angel investors. Oval has recently been sold to SMC.


News
June 2016

Sale of portfolio company, Cambridge CMOS Sensors

The second exit of the year so far from the Cambridge Capital Group portfolio, sees Cambridge CMOS Sensors (CCMOSS) sold to Austrian Microsystems (ams), the manufacturer of high performance sensors. CCMOSS is a spinout from Cambridge University which has been developing micro hotplate structures for gas sensing and infrared applications.

CCG members invested in three funding rounds, led by Cambridge Enterprise, the tech transfer agency for the university, and earned an attractive multiple of capital invested from the all cash transaction.


News
March 2016

Cambridge Capital Group portfolio company sold to Microsoft

AI business Touchtype Limited, developer of Swiftkey, the world beating predictive keyboard app, has been acquired by Microsoft in a cash deal worth $250 million. Angel investors from Cambridge Capital Group enjoyed a high financial return of almost ten times their capital investment Members of Cambridge Capital Group had first invested in the business in 2011 after inviting it to pitch at quarterly investment event when it was a fledgling start-up, and continued to support the company in subsequent capital funding rounds alongside major institutional investors including Octopus and Index.